OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

by · The Markets Daily

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten ratings firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $24.00.

Several brokerages have commented on KIDS. Piper Sandler cut their target price on OrthoPediatrics from $30.00 to $22.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. Needham & Company LLC reduced their price objective on OrthoPediatrics from $42.00 to $26.00 and set a “buy” rating for the company in a research note on Wednesday, October 29th. Stifel Nicolaus decreased their target price on shares of OrthoPediatrics from $32.00 to $20.00 and set a “buy” rating for the company in a research report on Friday, October 10th. Canaccord Genuity Group began coverage on shares of OrthoPediatrics in a research report on Wednesday, December 10th. They issued a “buy” rating and a $24.00 price objective for the company. Finally, Citigroup reissued an “outperform” rating on shares of OrthoPediatrics in a research report on Friday, October 10th.

Check Out Our Latest Analysis on KIDS

OrthoPediatrics Stock Performance

NASDAQ KIDS opened at $18.35 on Tuesday. The company has a current ratio of 7.40, a quick ratio of 3.52 and a debt-to-equity ratio of 0.28. OrthoPediatrics has a 1 year low of $15.28 and a 1 year high of $27.60. The firm has a market capitalization of $460.16 million, a price-to-earnings ratio of -9.41 and a beta of 1.09. The firm’s 50 day simple moving average is $17.86 and its 200 day simple moving average is $19.01.

OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last released its earnings results on Tuesday, October 28th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.02. The firm had revenue of $61.25 million for the quarter, compared to analysts’ expectations of $63.63 million. OrthoPediatrics had a negative return on equity of 6.86% and a negative net margin of 20.06%. As a group, research analysts expect that OrthoPediatrics will post -0.93 earnings per share for the current fiscal year.

Institutional Trading of OrthoPediatrics

A number of hedge funds have recently bought and sold shares of the company. Prosight Management LP boosted its holdings in OrthoPediatrics by 319.2% in the third quarter. Prosight Management LP now owns 308,707 shares of the company’s stock valued at $5,720,000 after acquiring an additional 235,060 shares in the last quarter. Millennium Management LLC grew its holdings in shares of OrthoPediatrics by 55.3% during the 1st quarter. Millennium Management LLC now owns 656,578 shares of the company’s stock worth $16,172,000 after acquiring an additional 233,873 shares during the period. Harbor Capital Advisors Inc. grew its holdings in shares of OrthoPediatrics by 116.5% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 333,959 shares of the company’s stock worth $7,173,000 after acquiring an additional 179,733 shares during the period. Deerfield Management Company L.P. raised its position in shares of OrthoPediatrics by 1,153.4% in the 3rd quarter. Deerfield Management Company L.P. now owns 194,109 shares of the company’s stock worth $3,597,000 after acquiring an additional 178,623 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its stake in shares of OrthoPediatrics by 112.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock valued at $4,937,000 after purchasing an additional 106,041 shares during the period. Institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

(Get Free Report)

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.

Recommended Stories